Keith E. Stockerl-Goldstein, MD ...

Dr. Keith Stockerl-Goldstein

Claim this profile

Washington University School of Medicine

Expert in Multiple Myeloma
Expert in Plasma Cell Neoplasm
28 reported clinical trials
46 drugs studied

About Keith Stockerl-Goldstein

Education:

  • Obtained a BA in Biology from Washington University, Saint Louis, Missouri, 1986.
  • Earned an MD from the University of California Los Angeles (UCLA) School of Medicine, 1991.
  • Completed Residency in Internal Medicine at Stanford University Hospital, 1993.
  • Undertook Fellowships in Bone Marrow Transplantation (1995) and Medical Oncology (1996) at Stanford University School of Medicine.

Experience:

  • Former Clinical Director of Adult Bone Marrow Transplantation Unit at Stanford University School of Medicine.
  • Currently serves as Program Director for Hematology-Medical Oncology & Hematology Focused Fellowship Training Program at Washington University School of Medicine.
  • Holds the position of Associate Program Director for Bone Marrow Transplantation at the same institution.

Area of expertise

1Multiple Myeloma
Global Leader
Keith Stockerl-Goldstein has run 13 trials for Multiple Myeloma. Some of their research focus areas include:
Stage IV
Stage III
Stage I
2Plasma Cell Neoplasm
Global Leader
Keith Stockerl-Goldstein has run 11 trials for Plasma Cell Neoplasm. Some of their research focus areas include:
Stage III
Stage IV

Affiliated Hospitals

Image of trial facility.
Washington University School Of Medicine
Image of trial facility.
Siteman Cancer Center-South County

Clinical Trials Keith Stockerl-Goldstein is currently running

More about Keith Stockerl-Goldstein

Clinical Trial Related1 year of experience running clinical trials · Led 28 trials as a Principal Investigator · 9 Active Clinical Trials
Treatments Keith Stockerl-Goldstein has experience with
  • Lenalidomide
  • Dexamethasone
  • Daratumumab
  • Bortezomib
  • Melphalan
  • Isatuximab

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Keith Stockerl-Goldstein specialize in?
Keith Stockerl-Goldstein focuses on Multiple Myeloma and Plasma Cell Neoplasm. In particular, much of their work with Multiple Myeloma has involved Stage IV patients, or patients who are Stage III.
Is Keith Stockerl-Goldstein currently recruiting for clinical trials?
Yes, Keith Stockerl-Goldstein is currently recruiting for 8 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Keith Stockerl-Goldstein has studied deeply?
Yes, Keith Stockerl-Goldstein has studied treatments such as Lenalidomide, Dexamethasone, Daratumumab.
What is the best way to schedule an appointment with Keith Stockerl-Goldstein?
Apply for one of the trials that Keith Stockerl-Goldstein is conducting.
What is the office address of Keith Stockerl-Goldstein?
The office of Keith Stockerl-Goldstein is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.